Infertility Clinical Trials
Through participation in various clinical trials, the physicians and scientists at Shady Grove Fertility continually strive to stay at the forefront of research and technology—to advance medical knowledge and improve patient care. Clinical trials are research studies that investigate whether a medical strategy or treatment approach is safe and effective. They also provide invaluable insights into which strategies and treatments work best. At Shady Grove Fertility, we follow strict scientific protocols to ensure patient safety and help produce reliable study results.
We encourage our patients to learn more about our ongoing trials, as they offer unique advantages, including, in some cases, free or discounted access to new treatments before they’re widely available. If you choose to participate in a clinical trial, you may receive the new approach being tested. At Shady Grove Fertility, as always, you will have the support of your physician and health care team.
Active Clinical Trials and Research Studies
Synchrony research study
Shady Grove Fertility is conducting the Synchrony research study to evaluate whether individualized timing of embryo transfer is superior compared to standard timing of embryo transfer. Preimplantation genetic screening (PGS) and endometrial receptivity analysis (ERA) will be provided to participants free of charge. You may qualify to participate if you meet the following eligibility criteria.
- Female age between 30 and 40 years
- Body mass index <40 kg/m2 at screening
- Normal uterine cavity
- No history of recurrent pregnancy loss, defined as two or more clinical pregnancy losses without live birth
- Having ≥ 1 euploid embryo available for embryo transfer
Please contact your physician, nurse or our clinical research team to determine if you
are eligible to participate at (888) 420-3329 or SGClinicalResearchTeam@integramed.com.
SPECTRA CLINICAL TRIAL
Shady Grove Fertility is currently seeking patients to participate in a fertility research study designed to evaluate if proteins secreted by a developing embryo correlate with in vitro fertilization (IVF) outcomes or aneuploidy. You may be eligible to participate if you meet the following criteria:
- Undergoing 1st IVF/ICSI cycle at Shady Grove Fertility
- Female age 37 to < 40 years
- Follicle stimulating hormone < 10 IU/L
- Anti-Müllerian hormone ≥ 2 ng/mL
- Antral follicle count ≥ 10
- Normal uterine cavity
- Normal semen analysis
- Undergoing preimplantation genetic screening (PGS)
- Will undergo a elective single embryo transfer (eSET) in a subsequent frozen embryo transfer (FET) cycle
Participants will receive PGS for embryos from the study cycle free of charge.
For information regarding enrolling in the SPECTRA study, speak with your nurse or doctor.
SUSTAIN RESEARCH STUDY
Shady Grove Fertility is conducting the SUSTAIN research study to evaluate vaginal progesterone for frozen embryo transfer (FET). Patients with an upcoming FET may be eligible to participate in this study.
Enrollment for the SUSTAIN research study is now complete.
Reproductive Window Study
Are you female between the ages of 18 to 40? Have you had a cancer diagnosis and cancer treatment? If so, the Reproductive Window Study needs you! The research team at Shady Grove Fertility, in collaboration with the researchers at UC San Diego, want to know how cancer treatment affects the reproductive health of young adult female cancer survivors. Participants will be followed for 18 months and asked to complete study activities at FOUR specific time points. Participants will receive a $10 gift card after completing each study activity.